𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Specific epstein-barr virus serological response in patients with nasopiiaryngeal carcinoma detected by immunoblotting

✍ Scribed by R. Cevenini; M. Donati; A. Moroni; U. Caliceti; A. Rinaldi-Ceroni; M. Placa

Publisher
Springer
Year
1988
Tongue
English
Weight
704 KB
Volume
4
Category
Article
ISSN
0393-2990

No coin nor oath required. For personal study only.

✦ Synopsis

The specific humoral immune response against Epstein-Barr virus (EBV) antigens in patients with nasopharyngeal carcinoma (NPC) was compared to that of patients with infectious mononucleosis (IM) and other EBV-seropositive subjects using immunoblotting technique. Almost all sera from EBV serologically associated NPC reacted reproducibly with a major group of polypeptides (four to six) of early antigen (EA) complex with molecular weights ranging from 50 kD to 58 kD, and with some additional polypeptides. Sera from IM-patients reproducibly recognized only one polypeptide of 50 kD belonging to the major group of polypeptides of EA-complex. Sera from patients with other types of head and neck cancer and relatively high levels of IgG antibody against viral capsid antigen (VCA) and EA did not react reproducibly with any of the EBV-associated proteins.

📜 SIMILAR VOLUMES

Epstein-barr virus detection in nasophar
Epstein-barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma
✍ Sen-Tien Tsai; Ying-Tai Jin; Risa B. Mann; Richard F. Ambinder 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views

## RESULTS. In specimens from 107 patients with NPC, EBV was detected by PCR in 2 Department of Pathology, the Johns Hopkins 97 cases (90.7%) and by EBER in situ hybridization in 105 cases (98.1%). In speci-

Immune responses to Epstein–Barr virus l
Immune responses to Epstein–Barr virus lytic proteins in patients with nasopharyngeal carcinoma
✍ Mei-Ying Liu; Yu-Tzu Huang; Tzung-Shiahn Sheen; Jen-Yang Chen; Ching-Hwa Tsai 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract Immune responses to three Epstein–Barr virus (EBV) lytic proteins, DNase, thymidine kinase (TK), and BMRF‐1 gene products (50/52 kDa diffused early antigen, EA‐D complex) were determined in EBV‐infected control individuals and patients with nasopharyngeal carcinoma (NPC). Immunofluoresc